Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Harald Wagner
Observed names:
H Wagner,
H. Wagner
Institution:
Macquarie University
Observed institutions:
LMU Klinikum,
Ludwig-Maximilians-Universität München,
Macquarie University
OpenAlex ID:
A5055953425
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
2014
·
G. von Minckwitz
, S. Loibl
, et al.
·
Annals of Oncology
·
144
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer
2014
·
Hans-Joachim Lück
, Kristina Lübbe
, et al.
·
Breast Cancer Research and Treatment
·
26
Efficacy and tolerability of ABVD and Stanford V for elderly advanced-stage Hodgkin lymphoma (HL): Analysis from the phase III randomized U.S. Intergroup Trial E2496.
2011
·
A. M. Evens
, F. Hong
, et al.
·
Journal of Clinical Oncology
·
10
A randomized phase III study to determine the efficacy of capecitabine in addition to a taxane and bevacizumab as first-line therapy in patients with metastatic breast cancer.
2013
·
Hans-Joachim Lueck
, Kristina Luebbe
, et al.
·
Journal of Clinical Oncology
·
4
Aromatase activity in a human lymphatic cell line
1987
·
S. Classen
, H. Wagner
, et al.
·
Journal of Steroid Biochemistry
·
3
Abstract P4-18-05: Male breast cancer— infusing a little blue into the sea of pink
2017
·
H Wagner
, J Boyages
·
Cancer Research
·
1
Phase II Study of a New Aromatase Inhibitor, 4-Hydroxy-Androstenedione, for the Treatment of Women with Advanced Breast Carinoma
1989
·
K. Possinger
, H. Wagner
, et al.
·
Beiträge zur Onkologie/Contributions to oncology
·
1
Abstract P5-19-11: Noninterventional study HELENA – Advanced (metastatic or locally recurrent, inoperable) HER2-positive breast cancer: First-Line trEatmeNt with pertuzumAb after adjuvant trastuzumab therapy
2015
·
Marc Thill
, Katja Ziegler-Löhr
, et al.
·
Cancer Research
A randomized phase III trial comparing nanoparticle-based paclitaxel with solvent-based paclitaxel as part of neoadjuvant chemotherapy for patients with early breast cancer (GeparSepto): GBG 69.
2013
·
Christian Jackisch
, Frank Wiebringhaus
, et al.
·
Journal of Clinical Oncology
Sachwortverzeichnis/Subject Index 1990
2010
·
M. Zügel
, E. Schäfer
, et al.
·
Onkologie
PDF
Hinweise für Autoren / Instructions to Authors
2010
·
M. Zügel
, E. Schäfer
, et al.
·
Onkologie
PDF
Inhalt, Vol. 13, No. 6, 1990
2009
·
M. Zügel
, E. Schäfer
, et al.
·
Onkologie
PDF
Sonderbände
2009
·
M. Zügel
, E. Schäfer
, et al.
·
Onkologie
PDF
Subject Index
1998
·
M. Zeitz
, R. Ullrich
, et al.
·
Pathobiology
PDF
Taxane in der Therapie des metastasierten Mammakarzinoms
1996
·
B. Hennemann
, H. Wagner
, et al.
·
University of Regensburg Publication Server (University of Regensburg)
Idarubicin: First-line Chemotherapy in Patients with Metastasized Breast Cancer and Favorable Prognosis
1989
·
H. Wagner
, K. Possinger
, et al.
·
Beiträge zur Onkologie/Contributions to oncology
Show more works
View as search
Works count:
16
Citation count:
189
H-index:
4
I10-index:
3
Year
Topic
Type